v3.26.1
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net loss $ (2,738) $ (1,550)
Add items not affecting cash    
Share-based compensation 1,265 1,420
Deferred income tax benefit (1,274) (567)
Foreign exchange (gain) loss (2,153) 2
Investment loss from Smackover Lithium 1,502 984
Fair value gain on Investment in Aqualung (91) (2,990)
Fair value loss (gain) on financial asset - FID 836 (741)
Amortization 126 332
Interest expense 4 10
Other 6 6
Net changes in non-cash working capital items:    
Other current assets and receivables (376) (3,376)
Accounts payable and accrued liabilities (2,790) (30)
Net cash used in operating activities (5,683) (6,500)
Investing activities    
Smackover Lithium capital contributions (17,875)  
Exploration and evaluation assets   (3)
Purchase of property, plant and equipment (4)  
Change in restricted cash (11) 58
Patents   (20)
Net cash (used in) provided by investing activities (17,890) 35
Financing activities    
Proceeds from at-the-market equity program ("ATM") 10,821 7,197
Exercise of Options 1,839  
Share issuance costs (269) (204)
Lease payments (47) (101)
Net cash provided by financing activities 12,344 6,892
Effect of exchange rates on cash (72) (35)
Net change in cash (11,301) 392
Cash, beginning of period 152,314 31,177
Cash, end of period $ 141,013 $ 31,569